Global Topical Use Acne Treatment Market, By Type (Inflammatory Acne, Cystic Acne, Post-Surgical/Wound Acne), Treatment (Medication, Therapeutic Devices), Drug (Antibiotics, Anti-Inflammatory Drugs, Antimicrobial, Combination Medications, Hormonal Agents, Oral Retinoid, Topical Retinoid), Device (Laser and Others), Administration (Oral and Topical), End User (Hospitals, Clinics) – Industry Trends and Forecast to 2029
Global Topical Use Acne Treatment Market Analysis and Size
Acne or acne vulgaris is known to be one of the most common skin conditions, escpecially among adolescents. This type of skin condition is generally caused by skin structures. This condition is characterized by blackheads, scarring, pimples, and oily skin.
The topical use acne treatment market was valued at USD 6.1 billion in 2021 and is expected to reach USD 12.70 billion by 2029, registering a CAGR of 9.60% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Topical Use Acne Treatment Market Definition
Acne medications refer to the drugs that are used for treating acne. These drugs consist of several prescription and over-the-counter medicines such as isotretinoin, salicylic acid, peroxide, retinoids, antibiotics, and benzoyl peroxide, among other oral contraceptives.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Inflammatory Acne, Cystic Acne, Post-Surgical/Wound Acne), Treatment (Medication, Therapeutic Devices), Drug (Antibiotics, Anti-Inflammatory Drugs, Antimicrobial, Combination Medications, Hormonal Agents, Oral Retinoid, Topical Retinoid), Device (Laser and Others), Administration (Oral and Topical), End User (Hospitals, Clinics)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Vyne Therapeutics Inc. (US), Galderma laboratories (US), Allergan (Ireland), Bayer AG (Germany), Bausch Health Companies Inc. (Canada), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc (UK), Teva Pharmaceutical Industries Ltd. (Jerusalem), Bayer AG (Germany), Dermira (US), GUTHY|RENKER (US), Reckitt Benckiser Group plc (UK), and ALLERGAN (Ireland), among others
|
|
Market Opportunities
|
|
Topical Use Acne Treatment Market Dynamics
Drivers
- Prevalence of Acne
The increase in the prevalence of acne diseases across the globe acts as one of the major factors driving the growth of topical use acne treatment market.
- Robust Pipeline
The rise in the presence of robust acne medications in pipeline accelerate the market growth.
- Use of Various Acne Treatment
The use of various acne treatment products such as antibiotics and retinoids, along with the rise in the awareness regarding the treatment further influence the market.
Opportunities
Furthermore, introduction of improved systemic treatment extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, medical tourism in developing economies will further expand the market.
Restraints/Challenges Global Topical Use Acne Treatment Market
On the other hand, presence of alternative treatment is expected to obstruct market growth. Also, side-effects associated with the use of acne medications are projected to challenge the topical use acne treatment market in the forecast period of 2022-2029.
This topical use acne treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on topical use acne treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Topical Use Acne Treatment Market
COVID-19 had impacted the topical use acne treatment market as the pandemic disrupted growth in many economies across various domains. The COVID-19 pandemic impacted the market due to the global lockdown and dermatology clinics were closed owing to safety. Several hospitals and clinics were transformed into COVID-19 centres utilizing pandemic-designated hospital structures. Patients were not able to visit dermatology clinics and pharmacies due to the lockdown. Telemedicine is getting popular as an effective way to patients with acne.
Recent Development
- Almirall announced the launch of Seysara in June’2021. The product is a novel tetracycline-derived oral antibiotic. It is known to be developed specifically for treating acne, and is commercially launched in the US market.
Global Topical Use Acne Treatment Market Scope and Market Size
The topical use acne treatment market is segmented on the basis of type, treatment, drug, device, administration and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Inflammatory Acne
- Cystic Acne
- Post-Surgical/Wound Acne
On the basis of type, the topical use acne treatment market is segmented into inflammatory acne, cystic acne and post-surgical/wound acne.
Treatment
- Medication
- Therapeutic Devices
On the basis of treatment, the topical use acne treatment market is segmented into medication and therapeutic devices. Medication is further sub segmented into segmented retinoid, antibiotics, and others. Retinoid is further sub segmented into adapalene, tretinoin and others. Antibiotics is further sub segmented into erythromycin, clindamycin and others. Therapeutic devices is further been segmented into lasers, microdermabrader, dermabradors, and others.
Drug
- Antibiotics
- Anti-Inflammatory Drugs
- Antimicrobial
- Combination Medications
- Hormonal Agents
- Oral Retinoid
- Topical Retinoid
On the basis of drug, the topical use acne treatment market is segmented into antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid and topical retinoid.
Device
- Laser
- Others
On the basis of device, the topical use acne treatment market is segmented into laser and others.
Administration
- Oral
- Topical
On the basis of administration, the topical use acne treatment market is segmented into oral and topical.
End User
- Hospitals
- Clinics
On the basis of end user, the topical use acne treatment market is segmented into hospitals and clinics.
Topical Use Acne Treatment Market Regional Analysis/Insights
The topical use acne treatment market is analysed and market size insights and trends are provided by country, type, treatment, drug, device, administration and end user as referenced above.
The countries covered in the topical use acne treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the topical use acne treatment market because of the developments related to acne therapeutics within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the high demand for acne therapeutics in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The topical use acne treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for topical use acne treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the topical use acne treatment market. The data is available for historic period 2010-2020.
Competitive Landscape and Topical Use Acne Treatment Market Share Analysis
The topical use acne treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to topical use acne treatment market.
Some of the major players operating in the topical use acne treatment market are
- Vyne Therapeutics Inc. (US)
- Galderma laboratories (US)
- Allergan (Ireland)
- Bayer AG (Germany)
- Bausch Health Companies Inc. (Canada)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Johnson & Johnson Services, Inc. (US)
- GlaxoSmithKline plc (UK)
- Teva Pharmaceutical Industries Ltd. (Jerusalem)
- Bayer AG (Germany)
- Dermira (US)
- GUTHY|RENKER (US)
- Reckitt Benckiser Group plc (UK)
- ALLERGAN (Ireland)
Research Methodology : Global Topical Use Acne Treatment Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-topical-use-acne-treatment-market
SKU-
